Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro.

Oncology reports

Volumn 9, Issue 5, 2002, Pages 929-935

  Castilleja, Agapito ^a   Ward, Nancy E ^a   Epstein, Richard B ^a   Kudelka, Andrzej P ^a   Gershenson, David M ^a   Efferson, Clay L ^a   O'Brian, Catherine A ^a   Ioannides, Constantin G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITOPE; TYROSINE; UBIQUITIN;

ANTIGEN PRESENTATION; ARTICLE; CELL CULTURE; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; OVARY; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; SERODIAGNOSIS; TIME; TUMOR ASSOCIATED LEUKOCYTE; WESTERN BLOTTING;

ANTIGEN PRESENTATION; BLOTTING, WESTERN; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; IMMUNOBLOTTING; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES, TUMOR-INFILTRATING; OVARY; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ERBB-2; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TUMOR CELLS, CULTURED; TYROSINE; UBIQUITIN;

MLCS; MLOWN;

EID: 0036725954     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.9.5.929     Document Type: Article

References (0)